Business Wire

NielsenIQ at Saudi Food Show: How Saudi Arabian Shoppers Successfully Navigate a Sea of Change

31.7.2023 09:00:00 EEST | Business Wire | Press release

Share

The aftershocks of the COVID-19 pandemic and the resultant shifts in the Saudi Arabian retail space, as well as food inflation, have generated a pullback on promotions, coupled with price increases. This has created a challenging environment for Saudi Arabian shoppers who have adapted quickly by shifting towards convenience and essential products.

This was the view of Andrey Dvoychenkov, NielsenIQ Middle East General Manager, as an introduction to the very first Saudi Food Show held in Riyadh and attended by a host of local and international retail professionals. His NielsenIQ presentation entitled Navigating Disruption During Times of Change provided the latest insights into the Saudi Arabian Fast Moving Consumer Goods (FMCG) sector.

Dvoychenkov said; “The Saudi market has recently been driven by price increases, with some prices raised by 10 to 15% during the year, which is mostly due to the rising cost of raw materials.” Dvoychenkov also highlighted the uniqueness of the Saudi Arabian market “where the majority of products and raw materials are imported, making it essential for industry players to navigate supply chain disruptions and consider local substitutes to create more stability.”

Dvoychenkov reported that as a result consumers in Saudi Arabia are scaling back on spending and optimising their budgets due to various lifestyle changes. These changes include cooking at home more often, minimizing waste and spending less on clothing and grooming.

An interesting dynamic is that despite their intention to curtail spending, Saudi shoppers seem to care deeply about quality. The premium product segment is growing ahead of the economy segment for local and international brands in food, with 65% of Saudi shoppers saying they are willing to pay more for quality products.

In terms of their response to the current challenging conditions they face, tactics that consumers are employing include weighing up the attributes that matter most, shopping online to get the best deals, and stopping buying certain categories of products. Interestingly, despite these changes and turbulent times, consumers in Saudi Arabia have the lowest percentage globally in perceiving themselves to be in a recession.

Dvoychenkov indicated that Saudi shoppers primarily spend their shopping time in hypermarkets and supermarkets, but there is a noticeable trend of faster growth in smaller format stores, such as grocery and convenience stores. The price increase in groceries is also significantly lower in these smaller format stores compared to traditional supermarkets.

The essence of "essentials" for modern shoppers

When it comes to choice and product selection, 77% of Saudi shoppers feel that food prices have increased and are only willing to buy essentials. Regarding the definition of "essentials" for modern shoppers, Dvoychenkov emphasized the need to be careful in how this term is perceived. To today's shoppers, essential products include staple items like bread with health benefits, like gluten-free flour that offer intrinsic benefits.

In addition, the NielsenIQ analysis highlighted the growing importance of health and wellness in consumers' minds, with many shoppers in Saudi Arabia willing to pay more for products containing healthy supplements, supporting the immune system, and made with natural ingredients.

The soaring rise of e-commerce and convenience formats

The presentation also revealed a significant 45% growth in online sales (Q1, 2023 vs. a year ago), with e-commerce playing an increasingly important role in the region. Dvoychenkov explained, “e-commerce growth is driven not only by convenience but also by an appetite for discounts. Online platforms offer a wide range of products, including ready-to-eat meals and foods catering to diverse consumer preferences.”

He added, “Convenience formats are also on the rise, with retailers like Viva, Gala, and Tamimi Express actively driving the expansion of these formats, offering everyday low prices and tailored assortments to meet consumers' convenience-seeking needs.”

The retailers' and manufacturers' challenge

With the changing market dynamics, retailers and manufacturers need to adapt their strategies to meet evolving consumer demands. For Saleem Iftikhar*, Country Leader for NielsenIQ in Saudi Arabia: “Price matching, direct price-cutting campaigns, and loyalty-building initiatives are some of the propositions retailers are adopting to cater to price-conscious consumers while providing a pleasant shopping experience.”

The NielsenIQ study finally emphasizes the importance of offering a well-organized store with a pleasant ambience, as well as excellent customer service. “Consumers are increasingly seeking price and promotion-related saving strategies, and although promo efficiency has seen a slight decline, our analysis highlights the need for retailers to engage customers through various components, including price and entertainment,” concludes Dvoychenkov.

* Saleem Iftikhar led a panel discussion with Chris Abboud, PepsiCo, and Shehim Mohammed, Lulu Group, on the first day of Saudi Food Summit - “Mitigating uncertainty, volatility and cost hikes in Food & Beverage industry.”

About NIQ

NIQ is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behaviour and revealing new pathways to growth. In 2023, NIQ combined with GfK, bringing together the two industry leaders with unparalleled global reach. With a holistic retail read and the most comprehensive consumer insights – delivered with advanced analytics through state-of-the-art platforms – NIQ delivers the Full View (TM).

NIQ is an Advent International portfolio company, with operations in 100+ markets, covering more than 90% of the world’s population. For more information, visit www.NIQ.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Melina Mammidou (Melina.Mammidou@nielseniq.com)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye